1. Mapping and Implementing a Safe Medicines Pathway & NNME the way forward Jennifer Dorey Pharmaceutical Adviser, NHS South --- South Central

2. Safe Medicines Pathway South Central Safe Medicines Pathway Map current medicines pathway ( 3 areas, one hospital) Month 1 Failure Mode and Effects Analysis to identify priorities for improvement Month 2 Simple interventions piloted and rolled out across NHS South ( 3 series) Month 3,4,5 Document interventions, impacts and outcomesMonth 6 Workshop to review and propose fundamentally changed Safe Medicines Pathway Month 7 Final report and action plan for development and implementation Month 8 Potential for research submissions and publications ongoing

3. NNME The way forward To do before March 2013 Identify savings for allergy & INR and decide whether to retain in metrics Clarify metric for insulin relating to self admin and include in metrics database Clarify metric for NSAID and include in metrics database Clarify metric for delayed and omitted medicines Ambulance to clarify position re diclofenac

4. NNME The way forward Now Core Practice Submission of data for metrics High risk injectable medicines (SCIP 1&2) Green bags Safe and secure storage of medicines in secondary care Commissioning Metrics, current, i.e. meds rec New, insulin and NSAID, omitted and delayed medicines Allergy and INR if agreed (see above)

5. NNME The way forward Procurement Pharmacist Provide data for NSAID and other metrics as appropriate Support high risk medicines in secondary care Safe Medicines Pathway SCIP 3 (high risk injectable medicines at home and in community) Facilitate community/prison/ambulance working group for safe and secure medicines storage Medicines Management e-learning Clinical aspects of CDs

6. NNME The way forward Issues still to be resolved Future of procure support Funding and hosting collation of metrics Future role of vte group and relevance of INR measurements Monitoring Accountable officer for CDs Co-ordination and leadership of Chief Pharmacists network Continued support from ESEE network to many of these projects

7. Key risk – long term future of: ESEE regional services – interim plans in place for the next two years, but ongoing support is key to many projects Procurement pharmacist role, including analyst support, need to confirm the long term viability of the post, through Procure or otherwise. Collaborative network of Chief pharmacists.